SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-008118
Filing Date
2017-05-02
Accepted
2017-05-02 16:25:48
Documents
66
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q adro-10q_20170331.htm 10-Q 2026820
2 EX-10.1 adro-ex101_429.htm EX-10.1 32404
3 EX-31.1 adro-ex311_7.htm EX-31.1 11744
4 EX-31.2 adro-ex312_6.htm EX-31.2 11855
5 EX-32.1 adro-ex321_9.htm EX-32.1 8398
  Complete submission text file 0001564590-17-008118.txt   7445223

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT adro-20170331.xml EX-101.INS 1696032
7 XBRL TAXONOMY EXTENSION SCHEMA adro-20170331.xsd EX-101.SCH 49199
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE adro-20170331_cal.xml EX-101.CAL 53633
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adro-20170331_def.xml EX-101.DEF 154657
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE adro-20170331_lab.xml EX-101.LAB 415073
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adro-20170331_pre.xml EX-101.PRE 306054
Mailing Address 740 HEINZ AVENUE BERKELEY CA 94710
Business Address 740 HEINZ AVENUE BERKELEY CA 94710 510-848-4400
ADURO BIOTECH, INC. (Filer) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37345 | Film No.: 17805389
SIC: 2834 Pharmaceutical Preparations